Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 1,079

The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.

The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*

Hwa, Vivian, Oh, Youngman, Rosenfeld, Ron G. · 1999 · Endocrine Reviews

Abstract

Over the last decade, the concept of an IGFBP family has been well accepted, based on structural similarities and on functional abilities to bind IGFs with high affinities. The existence of other potential IGFBPs was left open. The discovery of proteins with N-terminal domains bearing striking structural similarities to the N terminus of the IGFBPs, and with reduced, but demonstrable, affinity for IGFs, raised the question of whether these proteins were "new" IGFBPs (22, 23, 217). The N-terminal domain had been uniquely associated with the IGFBPs and has long been considered to be critical for IGF binding. No other function has been confirmed for this domain to date. Thus, the presence of this important IGFBP domain in the N terminus of other proteins must be considered significant. Although these other proteins appear capable of binding IGF, their relatively low affinity and the fact that their major biological actions are likely to not directly involve the IGF peptides suggest that they probably should not be classified within the IGFBP family as provisionally proposed (22, 23). The conservation of this single domain, so critical to high-affinity binding of IGF by the six IGFBPs, in all of the IGFBP-rPs, as well, speaks to its biological importance. Historically, and perhaps, functionally, this has led to the designation of an "IGFBP superfamily". The classification and nomenclature for the IGFBP superfamily, are, of course, arbitrary; what is ultimately relevant is the underlying biology, much of which still remains to be deciphered. The nomenclature for the IGFBP related proteins was derived from a consensus of researchers working in the IGFBP field (52). Obviously, a more general consensus on nomenclature, involving all groups working on each IGFBP-rP, has yet to be reached. Further understanding of the biological functions of each protein should help resolve the nomenclature dilemma. For the present, redesignating these proteins IGFBP-rPs simplifies the multiple names already associated with each IGFBP related protein, and reinforces the concept of a relationship with the IGFBPs. Beyond the N-terminal domain, there is a lack of structural similarity between the IGFBP-rPs and IGFBPs. The C-terminal domains do share similarities to other internal domains found in numerous other proteins. For example, the similarity of the IGFBP C terminus to the thyroglobulin type-I domain shows that the IGFBPs are also structurally related to numerous other proteins carrying the same domain (87). Interestingly, the functions of the different C-terminal domains in members of the IGFBP superfamily include interactions with the cell surface or ECM, suggesting that, even if they share little sequence similarities, the C-terminal domains may be functionally related. The evolutionary conservation of the N-terminal domain and functional studies support the notion that IGFBPs and IGFBP-rPs together form an IGFBP superfamily. A superfamily delineates between closely related (classified as a family) and distantly related proteins. The IGFBP superfamily is therefore composed of distantly related families. The modular nature of the constituents of the IGFBP superfamily, particularly their preservation of an highly conserved N-terminal domain, seems best explained by the process of exon shuffling of an ancestral gene encoding this domain. Over the course of evolution, some members evolved into high-affinity IGF binders and others into low-affinity IGF binders, thereby conferring on the IGFBP superfamily the ability to influence cell growth by both IGF-dependent and IGF-independent means (Fig. 10). A final word, from Stephen Jay Gould (218): "But classifications are not passive ordering devices in a world objectively divided into obvious categories. Taxonomies are human decisions imposed upon nature--theories about the causes of nature's order. The chronicle of historical changes in classification provides our finest insight into conceptual revolutions

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/edrv.20.6.0382

Cites

165 of 165 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 56

  1. Rosenfeld, 1987, Somatomedin action and tissue growth-factor receptors, In: Robbins R, Melmed S (eds) Acromegaly. Plenum Press, New York, pp, 45
  2. Lowe, 1991, Biological actions of the insulin-like growth factors, In: LeRoith D (ed) Insulin-like Growth Factors: Molecular and Cellular Aspects. CRC Press, Boca Raton, FL, pp, 49
  3. Oh, 1998, IGF-independent actions of IGFBPs, In: Takano K, Hizuka N, Takahashi S-I (eds) Molecular Mechanisms to Regulate the Activities of Insulin-Like Growth Factors. Elsevier, Amsterdam, pp, 123
  4. Luthman, 1989, Human insulin-like growth-factor-binding protein: low-molecular-mass form: protein sequence and cDNA cloning., Eur J Biochem, 180, 259, 10.1111/j.1432-1033.1989.tb14641.x · doi:10.1111/j.1432-1033.1989.tb14641.x
  5. Grundmann, 1988, Cloning of cDNA encoding human placental protein 12 (PP12): Binding protein for IGF-1 and somatomedin., Nucleic Acids Res, 16, 8711, 10.1093/nar/16.17.8711 · doi:10.1093/nar/16.17.8711
  6. Akaogi, 1994, Cell adhesion activity of a 30-kDa major secreted protein from human bladder carcinoma cells., Biochem Biophys Res Commun, 198, 1046, 10.1006/bbrc.1994.1149 · doi:10.1006/bbrc.1994.1149
  7. Schoen, 1995, Cloning and characterization of a chick embryo cDNA and gene fro IGF-binding protein-2., J Mol Endocrinol, 15, 49, 10.1677/jme.0.0150049 · doi:10.1677/jme.0.0150049
  8. Forbes, 1998, Localization of an insulin-like growth factor (IGF) binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain., J Biol Chem, 273, 4647, 10.1074/jbc.273.8.4647 · doi:10.1074/jbc.273.8.4647
  9. Rodakis, 1983, The B multigene family of chorion proteins in saturniid silkmoths., J Mol Evol, 19, 322, 10.1007/BF02101635 · doi:10.1007/bf02101635
  10. Jordi, 1989, Nucleotide sequence of the gene coding for the peplomer protein (= spike protein) of infectious bronchitis virus, strain D274., Nucleic Acids Res, 17, 6726, 10.1093/nar/17.16.6726 · doi:10.1093/nar/17.16.6726
  11. Evans, 1990, A gene from pea (Pisum sativum L.) with homology to metallothion genes., FEBS Lett, 262, 29, 10.1016/0014-5793(90)80145-9 · doi:10.1016/0014-5793(90)80145-9
  12. Bohn, 1980, New placental protein (PP15) with immunosuppressive properties., Arch Gynecol, 230, 167, 10.1007/BF02108272 · doi:10.1007/bf02108272
  13. Zapf, 1988, Isolation and NH2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors., Biochem Biophys Res Commun, 156, 1187, 10.1016/S0006-291X(88)80758-7 · doi:10.1016/s0006-291x(88)80758-7
  14. Conover, 1993, Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells., J Clin Endocrinol Metab, 76, 1153
  15. Bach, 1993, Rat PC12 pheochromocytoma cells synthesize insulin-like growth factor-binding protein-6., Endocrinology, 133, 990, 10.1210/endo.133.3.7689963 · doi:10.1210/endo.133.3.7689963
  16. Hoeck, 1994, Identification of the major sites of phosphorylation in IGF binding protein-3., J Cell Biochem, 56, 262, 10.1002/jcb.240560220 · doi:10.1002/jcb.240560220
  17. Coverley, 1995, Regulation of insulin-like growth factor (IGF) binding protein-3 phosphorylation by IGF-I., Endocrinology, 136, 5778, 10.1210/endo.136.12.7588336 · doi:10.1210/endo.136.12.7588336
  18. Morabito, 1995, Molecular cloning of bullfrog saxiphilin: a unique relative of the transferrin family that binds saxitoxin. (Correction)., Proc Natl Acad Sci USA, 92, 6651, 10.1073/pnas.92.14.6651 · doi:10.1073/pnas.92.14.6651
  19. Booth, 1996, Structure-function relationships in the heparin-binding c-terminal region of insulin-like growth factor binding protein-3., Growth Regul, 6, 206
  20. Smith, 1994, Insulin-like growh factor-binding protein-3 (IGFBP-3) concentration in rat Sertoli cell-conditioned medium is regulated by a pathway involving association of IGFBP-3 with cell surface proteoglycans., Endocrinology, 135, 359, 10.1210/endo.135.1.7516869 · doi:10.1210/endo.135.1.7516869
  21. Cohen, 1992, Prostate specific antigen is an IGF binding protein-3 (IGFBP-3) protease found in seminal plasma., J Clin Endocrinol Metab, 75, 1046
  22. Fielder, 1994, Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3., Growth Regul, 1, 164
  23. Lalou, 1997, Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity., C R Acad Sci III, 320, 621, 10.1016/S0764-4469(97)85695-8 · doi:10.1016/s0764-4469(97)85695-8
  24. Vorwerk, 1998, Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine., J Clin Endocrinol Metab, 83, 1392, 10.1210/jcem.83.4.4858 · doi:10.1210/jcem.83.4.4858
  25. Cheung, 1994, Glucocorticoid regulation of an insulin-like growth factor-binding protein-4 protease produced by a rat neuronal cell line., Endocrinology, 135, 1328, 10.1210/endo.135.4.7523095 · doi:10.1210/endo.135.4.7523095
  26. Chernausek, 1995, Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4): localization of cleavage sit to non-homologous region of native IGFBP-4., J Biol Chem, 270, 11377, 10.1074/jbc.270.19.11377 · doi:10.1074/jbc.270.19.11377
  27. Spencer, 1995, A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3., Prog Growth Factor Res, 6, 209, 10.1016/0955-2235(96)00008-7 · doi:10.1016/0955-2235(96)00008-7
  28. Baxter, 1995, Modulations of human IGF binding protein-3 activity by structural modification., Prog Growth Factor Res, 6, 215, 10.1016/0955-2235(95)00004-6 · doi:10.1016/0955-2235(95)00004-6
  29. Qin, 1998, Structure-function analysis of the human insulin-like growth factor binding protein-4., J Biol Chem, 273, 23509, 10.1074/jbc.273.36.23509 · doi:10.1074/jbc.273.36.23509
  30. Hobba, 1996, The insulin-like growth factor (IGF) binding site of bovine insulin-like growth factor binding protein-2 (bIGFBP-2) probed by iodination., J Biol Chem, 271, 30529, 10.1074/jbc.271.48.30529 · doi:10.1074/jbc.271.48.30529
  31. Hobba, 1998, Alanine screening mutagenesis established tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding., J Biol Chem, 273, 19691, 10.1074/jbc.273.31.19691 · DOI
  32. Brinkman, 1991, Mutations in the C-terminal part of insulin-like growth factor (IGF)-binding protein-1 result in dimer formation and loss of IGF binding capacity., Mol Endocrinol, 5, 987, 10.1210/mend-5-7-987 · doi:10.1210/mend-5-7-987
  33. Bramani, 1999, Amino acids within the extracellular matrix (ECM) binding region (201–218) of rat insulin-like growth factor binding protein (IGFBP-5) are important determinants in binding IGF-I., J Mol Endocrinol, 23, 117, 10.1677/jme.0.0230117 · doi:10.1677/jme.0.0230117
  34. Ho, 1997, Characterization of truncated insulin-like growth factor-binding protein-2 in human milk., Endocrinology, 138, 3811, 10.1210/endo.138.9.5415 · doi:10.1210/endo.138.9.5415
  35. Wang, 1988, Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors., Biochem Biophys Res Commun, 157, 718, 10.1016/S0006-291X(88)80309-7 · doi:10.1016/s0006-291x(88)80309-7
  36. Yamanaka, 1999, Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells., Endocrinology, 140, 1319, 10.1210/endo.140.3.6566 · doi:10.1210/endo.140.3.6566
  37. Fowlkes, 1996, Characterization of glycosaminoglycan-binding domains present in insulin-like growth factor-binding protein-3., J Biol Chem, 271, 14676, 10.1074/jbc.271.25.14676 · doi:10.1074/jbc.271.25.14676
  38. Rees, 1998, Inhibition of IGFBP-5 binding to extracellular matric and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5., J Cell Biochem, 71, 375, 10.1002/(SICI)1097-4644(19981201)71:3<375::AID-JCB6>3.0.CO;2-M · doi:10.1002/(sici)1097-4644(19981201)71:3<375::aid-jcb6>3.0.co;2-m
  39. Radulescu, 1994, Nuclear localization signal in insulin-like growth factor-binding protein type 3., Trends Biochem Sci, 19, 278, 10.1016/0968-0004(94)90004-3 · doi:10.1016/0968-0004(94)90004-3
  40. Andress, 1998, Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor, Am J Physiol, 274, E744
  41. Damon, 1997, Developmental regulation of Mac25/insulin-like growth factor-binding protein-7 expression in skeletal myogenesis., Exp Cell Res, 237, 192, 10.1006/excr.1997.3787 · doi:10.1006/excr.1997.3787
  42. Pereira, 1999, Parathyroid hormone increases mac25/insulin-like growth factor-binding protein-related protein-1 expression in cultured osteoblasts., Endocrinology, 140, 1998, 10.1210/endo.140.5.6692 · doi:10.1210/endo.140.5.6692
  43. Inoguchi, 1986, Reducted serum-stimulatory activity on prostacyclin production by cultured aortic endothelial cells in diabetes mellitus., Haemostasis, 16, 447
  44. Inoguchi, 1989, Abnormality in porstacyclin-stimulatory activity in sera from diabetes., Metabolism, 38, 837, 10.1016/0026-0495(89)90229-1 · doi:10.1016/0026-0495(89)90229-1
  45. Groot, 1985, The role of thrombin in the regulation of the endothelial prostaglandin production., Biochim Biophys Acta, 846, 342, 10.1016/0167-4889(85)90004-7 · doi:10.1016/0167-4889(85)90004-7
  46. Rosenfeld, 1998, Editorial: The blind men and the elephant - a parable for the study of insulin-like growth factor binding proteins., Endocrinology, 139, 5, 10.1210/endo.139.1.5746 · doi:10.1210/endo.139.1.5746
  47. Masakado, 1995, Immunohistochemical localization of a novel peptide, prostacyclin-stimulating factor (PSF), in human tissues., Thromb Haemost, 74, 1407, 10.1055/s-0038-1649955 · doi:10.1055/s-0038-1649955
  48. Umeda, 1996, Prostacyclin-stimulating factor, novel protein, and diabetic angiopathy, Diabetes, 45, S111, 10.2337/diab.45.3.S111 · doi:10.2337/diab.45.3.s111
  49. Haustein, 1998, Pathophysiology of scleroderma: an update., J Eur Acad Dermatol Vernereol, 11, 1, 10.1111/j.1468-3083.1998.tb00945.x · doi:10.1111/j.1468-3083.1998.tb00945.x
  50. Martin, 1994, Regulation and actions of the insulin-like growth factor binding proteins, In: Kohler PO (ed) Current Opinion in Endocrinology and Diabetes. Current Science, Philadelphia, pp, 16
  51. Martinerie, 1996, Regulation of nov by WT1: a potential role for nov in nephrogenesis., Oncogene, 12, 1479
  52. Hainsworth, 1992, Rearrangement of chromosone 1p in breast cancer correlates with poor prognostic features., Br J Cancer, 66, 131, 10.1038/bjc.1992.229 · doi:10.1038/bjc.1992.229
  53. Gehring, 1995, The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma., Cancer Res, 55, 5366
  54. Mizushima, 1996, Isolation and characterization of the human chromosomal gene for prostacyclin-stimulating factor., J Biochem, 120, 929, 10.1093/oxfordjournals.jbchem.a021508 · doi:10.1093/oxfordjournals.jbchem.a021508
  55. Collet, 1998, How many insulin-like growth factor binding proteins?, Mol Cell Endocrinol, 139, 1, 10.1016/S0303-7207(98)00078-1 · doi:10.1016/s0303-7207(98)00078-1
  56. Zazzi, 1998, Structure and transcription regulation of the human insulin-like growth factor binding protein 4 gene (IGFBP4)., Genomics, 49, 401, 10.1006/geno.1998.5283 · doi:10.1006/geno.1998.5283

Cited by

See all 1,079

Metadata

Authors
Hwa, V., Oh, Y., & Rosenfeld, R. G.
Venue
Endocrine Reviews
Published
1999-12-01
Volume
20
Issue
6
Pages
761-787
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2144678487
Cited by
1,079
References
165
FWCI
25.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.